The scientific seminar on “A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen,  in Duchenne muscular dystrophy”

The scientific seminar on “A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy”

A scientific seminar on A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen,  in Duchenne muscular dystrophy was held on 03 Apr., 2018, Tuesday at the conference room of National Institute of Neuro-Sciences & Hospital (NINS). The seminar was jointly organized by Weekly Journal Club of NINS & UniMed Pharma.

The program was chaired by Prof. Dr. Quazi Deen Mohammad, Director , NINS and co-chaired by Prof. Dr. Badrul Alam Mandal, Joint Director, NINS. The repporteur of the mentioned program was Dr. Mahmudul Islam, Asst. Professor, NINS. Topic presentation & answer for audience questions regarding the topic was given by Dr. Zobaida Nasrin, Endocrinologist, NINS.  Panel discussion was done by Dr. Azharul Haque, Professor, Dept. of Neurology, NINS, & Dr. Maliha Hakim, Professor, Dept. of Neurology, NINS. 160 doctors from Neuro-Medicine, Neuro-surgery and Physical Medicine were present at this program.

Product presentation (Demelon) was given by Mr. Md. Hosniwat Khadem, Sr. Product Manager, UniMed Pharma. Closing speech was given by Prof. Dr. Quazi Deen Mohammad, Director, NINS.